Skip to content

13F-HR filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 52 holding rows worth $3,375,426,000.

Accession
0001534261-21-000002
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 52 entries on the cover page, a total value of $3,375,426,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,375,426,000 with VALUE read as thousands by filing date, 13F file number 028-17113. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
INVITAE CORP46185L103COM12,298,038$514,181,000thousands by filing date
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock7,440,107$296,786,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM3,050,000$277,337,000thousands by filing date
EXACT SCIENCES CORP COM30063P105Stock1,485,149$196,767,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM1,550,000$173,833,000thousands by filing date
RELAY THERAPEUTICS INC COM75943R102Stock3,808,894$158,298,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM1,000,000$141,290,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock5,000,000$129,700,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock1,310,000$109,726,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM2,375,000$102,909,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock780,000$101,377,000thousands by filing date
CODEXIS INC192005106COM4,330,000$94,524,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM530,000$90,360,000thousands by filing date
CAREDX INC14167L103COM1,193,335$86,457,000thousands by filing date
REVOLUTION MEDICINES INC COM76155X100Stock1,634,535$64,711,000thousands by filing date
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock1,785,000$51,408,000thousands by filing date
GENERATION BIO CO37148K100COM1,611,214$45,678,000thousands by filing date
DERMTECH INC24984K105COM1,370,000$44,443,000thousands by filing date
BURNING ROCK BIOTECH LTD12233L107SPONSORED ADS1,922,150$44,402,000thousands by filing date
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock713,125$42,167,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock266,430$40,793,000thousands by filing date
BLUEBIRD BIO INC09609G100COM915,000$39,592,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock3,650,000$39,566,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR150,000$38,759,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM460,000$37,554,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM810,000$35,081,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock780,555$32,354,000thousands by filing date
DIANTHUS THERAPEUTICS INC COM55910K108Stock3,346,034$26,233,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR190,000$25,715,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM550,000$25,520,000thousands by filing date
ALECTOR INC014442107COMMON STOCK1,650,000$24,965,000thousands by filing date
ALLOGENE THERAPEUTICS INC019770106COM945,000$23,852,000thousands by filing date
908 DEVICES INC COM65443P102Stock406,502$23,150,000thousands by filing date
TAYSHA GENE THERAPIES INC877619106COMMON STOCK820,440$21,774,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM601,515$20,361,000thousands by filing date
BERKELEY LTS INC084310101COM200,000$17,882,000thousands by filing date
KRONOS BIO INC50107A104COM583,436$17,427,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM1,080,000$16,853,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,241,176$14,534,000thousands by filing date
AMYRIS INC03236M200COM NEW2,000,000$12,350,000thousands by filing datecall
SYNDAX PHARMACEUTICALS INC87164F105COM450,000$10,008,000thousands by filing date
BLACK DIAMOND THERAPEUTICS I09203E105COM289,395$9,275,000thousands by filing date
TURNING PT THERAPEUTICS90041T108COM75,000$9,139,000thousands by filing date
SEER INC81578P106COM CL A150,000$8,421,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock200,000$8,048,000thousands by filing date
DYNE THERAPEUTICS INC COM26818M108Stock370,000$7,770,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM120,000$7,432,000thousands by filing date
FOGHORN THERAPEUTICS INC344174107COMMON STOCK216,216$4,383,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/99996,250,000$4,313,000thousands by filing date
CODIAK BIOSCIENCES INC192010106COM76,688$2,477,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM50,000$2,166,000thousands by filing datecall
C4 THERAPEUTICS INC12529R107COM STK40,000$1,325,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001534261-21-000002this filing2021-02-16acceptance time not in the bulk data set